Commission Regulation (EC) No 1277/2005 of 27 July 2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors Text with EEA relevance
Modified by
- Commission Regulation (EC) No 297/2009of 8 April 2009amending Regulation (EC) No 1277/2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors, 32009R0297, April 9, 2009
- Commission Regulation (EU) No 225/2011of 7 March 2011amending Commission Regulation (EC) No 1277/2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors, 32011R0225, March 8, 2011
(a) the full name and address of the applicant; (b) the full name of the responsible officer; (c) a description of the position and tasks of the responsible officer; (d) the full addresses of the business premises; (e) the description of all the places of storage, production, manufacture and processing of scheduled substances; (f) information showing that adequate measures have been taken against the unauthorised removal of scheduled substances from the places listed in point (e); (g) the name and the CN code of the scheduled substances as stated in Annex I to Regulation (EC) No 273/2004; (h) in the case of a mixture or natural product an indication of the following: (i) the name of the mixture or natural product; (ii) the name and CN code of the scheduled substances as stated in Annex I to Regulation (EC) No 273/2004 in the mixture or natural product; (iii) the maximum percentage of such scheduled substances in the mixture or natural product;
(i) a description of the envisaged type of operations referred to in Article 3 of Regulation (EC) No 273/2004; (j) an authenticated copy of the Register of companies or activities, where appropriate; (k) a certificate of good conduct of the applicant and the responsible officer or a document showing that they offer the necessary guarantee for the proper conduct of the operations, as appropriate.
(a) a licence which covers all scheduled substances and all operations per business premises; (b) a licence which covers all scheduled substances and all operations per Member State.
(a) the addition of a scheduled substance; (b) the start of a new operation; (c) the change of the location of the business premises where the operations take place.
(i) the date of expiry of validity where a term of validity has been fixed in accordance with Article 9 of this Regulation or in accordance with Article 3(5) of Regulation (EC) No 273/2004; (ii) the date of commencement of validity of the new licence.
(a) the conditions set out in Article 5(1) of this Regulation are no longer fulfilled; (b) there are reasonable grounds for suspecting that the scheduled substances are intended for the illicit manufacture of narcotic drugs or psychotropic substances; (c) the licence holder has not used the licence for a period of three years.
(a) the provision of documentation referred to in Article 3 of Regulation (EC) No 111/2005; (b) the obligation to appoint a responsible officer set out in Article 3 of this Regulation.
(a) exports of scheduled substances subject to an export authorisation; (b) all imports of scheduled substances of Category 1 requiring an import authorisation or all cases where scheduled substances of Category 2 are entered into a free zone of control type II, placed into a suspensive procedure other than transit, or released for free circulation; (c) all intermediary activities involving scheduled substances of Categories 1 and 2.
(a) countries with whom the Community has concluded a specific agreement on drug precursors; (b) third countries which have requested to receive pre-export notifications in accordance with Article 12(10) of the United Nations Convention.
(a) where during previous exports the operator has shown the capacity to fulfil all obligations in relation to those exports, and has not committed any offences against relevant legislation; (b) where the competent authority can satisfy itself as to the licit purposes of those export operations.
(a) the names and addresses of the exporter, importer in the third country, and the ultimate consignee; (b) the name of the scheduled substance, as stated in the Annex to Regulation (EC) No 111/2005, or, in the case of a mixture or natural product, its name and CN code and the name of any scheduled substance, as stated in the Annex to Regulation (EC) No 111/2005, contained in the mixture or natural product; (c) the maximum quantity of the scheduled substance intended for export; (d) the intended specific time period for the export operations.
(a) the of name of the scheduled substances; if known their origin, provenance and destination; (b) the quantity of the scheduled substances, their customs status and the means of transport used.
Box 1 (Licence holder): The name of the responsible officer may be added. Box 3 (validity/end): Specify the term of validity or whether operators are obliged to demonstrate at intervals not exceeding three years that the conditions under which the licence was granted are still fulfilled. Box 4 (scheduled substances): Name of the scheduled substance as stated in the Annex, or, in the case of a mixture or a natural product, its name and the name of any scheduled substance, as stated in the Annex, contained in the mixture or in the natural product. Indicate salts, where appropriate. Box 4 (CN code): In addition to the CN code, the CAS number may be added. Box 4 (operation): Specify export, import and/or intermediary activities. In the case of import, specify whether storage, working, processing, use, usual forms of handling and/or release for free circulation, where appropriate. For operations covered by Regulation (EC) No 273/2004, specify: storage, production, manufacture, processing, trade, distribution and/or brokering. Box 4 (business premises): In the case of intermediary activities referred to in Article 2 of Regulation (EC) No 111/2005, the business premises need not be specified.
Substance | Quantity |
---|---|
Acetone | |
Ethyl ether | |
Methylethylketone | |
Toluene | |
Sulphuric acid | |
Hydrochloric acid |
Substance | Destination |
---|---|
Any third country | |
| |
|
Substance | Destination |
---|---|
| |
|
Box "Part A": Indicate whether the MCRN covers one or several export operations. Where it covers several operations, indicate the intended time frame. Box 14 (quantity and weight): In the case of a MCRN to cover several export operations, indicate the maximum quantity and weight. Item 18 (Departure date): In the case of a MCRN to cover several export operations, this box must be filled out indicating the final estimated departure date.
Indicate in block letters the name of the applicant or, where appropriate, of the authorised representative who signs this application. The signature by the applicant or authorised representative, according to the modalities provided for by the Member State concerned, indicates that the person concerned is declaring that all the particulars provided on the application are correctly and fully stated. Without prejudice to the possible application of penal provisions, this declaration is equivalent to the engagement of responsibility, under the provisions in force in the Member States, in respect of the following: the accuracy of the information given in the declaration; the authenticity of any documents attached; the observance of all the obligations inherent in the export of scheduled substances listed in the Annex to Regulation (EC) No 111/2005.
Whenever the authorisation is issued by means of a computerised procedure, that authorisation may not contain the signature of the applicant in this box, if the application as such contains such signature.
Indicate in block letters the name of the applicant or, where appropriate, of his authorised representative who signs this application. The signature by the applicant or his authorised representative, according to the modalities provided for by the Member State concerned, indicates that the person concerned is declaring that all the particulars provided on the application are correctly and fully stated. Without prejudice to the possible application of penal provisions, this declaration is equivalent to the engagement of responsibility, under the provisions in force in the Member States, in respect of the following: the accuracy of the information; the authenticity of any documents attached; the observance of all other obligations.
Whenever the authorisation is issued by means of a computerised procedure, that authorisation may not contain the signature of the applicant in this box, if the application as such contains such signature.